New Employment Inducement Grants Announced by Arcus Biosciences

Arcus Biosciences announces new employment inducement grants, including options to purchase 7,050 shares of common stock and restricted stock units to acquire 3,550 shares. The equity awards were granted pursuant to the Company's 2020 Inducement Plan. The new employees will join the company's efforts to develop treatments for cancer and inflammatory and autoimmune disorders.